Microcrystalline tyrosine(MCT ®): A depot adjuvant in licensed allergy immunotherapy offers new opportunities in Malaria.

G. Cabral-Miranda, et al. Vaccines 2017, 5(4), 32.

Virus-Like Particle (VLP) Plus Microcrystalline Tyrosine (MCT) Adjuvants Enhance Vaccine Efficacy Improving T and B Cell Immunogenicity and Protection against Plasmodium berghei/vivax

G. Cabral-Miranda, et al. Vaccines 2017, 5(2), 10

Comparison of a novel microcrystalline tyrosine adjuvant with aluminium hydroxide for enhancing vaccination against seasonal influenza

M.D. Heath, et al. BMC Infectious Diseases (2017) 17:232

Clinical use of adjuvants in allergen immunotherapy

L. Klimek, et al. Expert Review of Clinical Immunology, 2017, 13:6, 599-610

Analysis of aluminium in rat following administration of allergen immunotherapy using either aluminium or microcrystalline-tyrosine-based adjuvants

S. A. McDougall, et al. Bioanalysis (2016) 8(6), 547–556

The adsorption of allergoids and 3-0-desacyl-4'-monophosphoryl lipid A (MPL®) to microcrystalline tyrosine (MCT) in formulations for use in allergy immunotherapy.

A.J. Bell, et al. Journal of Inorganic Biochemistry 152 (2015) 147–153

DOPS Adjuvant Confers Enhanced Protection against Malaria for VLP-TRAP Based Vaccines

G.Cabral-Miranda, et al. MDPI (2018) 6(4):107

Vaccination with nanoparticles combined with micro adjuvants protects against cancer

M. Mohsen, et al. Journal for Immunotherapy of Cancer (2019) 7:114

Shaping Modern Vaccines: Adjuvant Systems Using MicroCrystalline Tyrosine (MCT®)

M.D. Heath, et al. Frontiers Immunology (2020) 11:594911